Your browser doesn't support javascript.
loading
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
Villablanca, Judith G; Volchenboum, Samuel L; Cho, Hwangeui; Kang, Min H; Cohn, Susan L; Anderson, Clarke P; Marachelian, Araz; Groshen, Susan; Tsao-Wei, Denice; Matthay, Katherine K; Maris, John M; Hasenauer, Charlotte E; Czarnecki, Scarlett; Lai, Hollie; Goodarzian, Fariba; Shimada, Hiro; Reynolds, Charles Patrick.
Afiliação
  • Villablanca JG; Department of Pediatrics, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Volchenboum SL; Department of Pediatrics, University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
  • Cho H; Cancer Center and Departments of Cell Biology & Biochemistry, Pediatrics, and Medicine, Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas.
  • Kang MH; Cancer Center and Departments of Cell Biology & Biochemistry, Pediatrics, and Medicine, Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas.
  • Cohn SL; Department of Pediatrics, University of Chicago Comprehensive Cancer Center, Chicago, Illinois.
  • Anderson CP; City of Hope National Medical Center, Duarte, California.
  • Marachelian A; Department of Pediatrics, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Groshen S; Department of Preventative Medicine Statistics, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Tsao-Wei D; Department of Preventative Medicine Statistics, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Matthay KK; Department of Pediatrics, University of California San Francisco, San Francisco, California.
  • Maris JM; Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Hasenauer CE; Department of Pediatrics, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Czarnecki S; Department of Pediatrics, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Lai H; Department of Radiology, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Goodarzian F; Department of Radiology, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Shimada H; Department of Pathology and The Saban Research Institute, Children's Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Reynolds CP; Cancer Center and Departments of Cell Biology & Biochemistry, Pediatrics, and Medicine, Texas Tech University Health Sciences Center School of Medicine, Lubbock, Texas.
Pediatr Blood Cancer ; 63(8): 1349-56, 2016 08.
Article em En | MEDLINE | ID: mdl-27092812
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Antineoplásicos Alquilantes / Butionina Sulfoximina / Agonistas Mieloablativos / Melfalan / Neuroblastoma / Antimetabólitos Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Antineoplásicos Alquilantes / Butionina Sulfoximina / Agonistas Mieloablativos / Melfalan / Neuroblastoma / Antimetabólitos Antineoplásicos Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2016 Tipo de documento: Article